Dan Schoen

Dan Schoen has extensive experience in market access and pricing within the biotechnology and pharmaceuticals sectors, currently serving as the Director of the TTR Franchise for Global Market Access and Pricing at Alnylam Pharmaceuticals since June 2022. In this role, Dan leads global pricing and reimbursement strategies for Onpattro and Amvuttra, focusing on the cardiomyopathy launch and franchise expansions, while collaborating across functions to implement strategic pricing initiatives. Prior to Alnylam, Dan held various leadership roles at AbbVie, including overseeing the c-MET franchise and the lifecycle strategy for Venetoclax. Dan's career also encompasses finance management positions at Baxter International and Abbott, as well as early experience in business development at Bank of America. Dan holds an MBA from the Lake Forest Graduate School of Management, alongside Bachelor's degrees in Finance and Electrical and Electronics Engineering from Michigan State University and the University of Michigan, respectively.